News
- Details
From May 22 to 25, 2019, Medsintez took part in the VIII (XXVI) National Congress of Endocrinologists "Personified Medicine and Practical Health Care".
- Details
From April 16 to 19, Urals Healthcare 2019, the specialized International Exhibition and Forum, was held at the Yekaterinburg Expo Centre, where a stand of Medsintez was presented too. The forum exhibition of medical equipment, tools, supplies, pharmaceuticals as well as medical and spa services was held for the first time ever.
- Details
On December 21, 2018, Epidemiology And Treatment Of Allergic Diseases, a scientific and practical conference of the Sverdlovsk region's allergologists and immunologists, was held, where Triazavirin, the domestic antiviral drug, was recommended as a treatment for viral infections that exacerbate bronchial asthma.
- Details
Today, the company has a developed technology for obtaining the RosinsulinAspart and RosinsulinGlargin substances as well as their dosage forms.
- Details
On November 15, 2018, within the framework of a regular meeting of the Sverdlovsk Association of Endocrinologists, the results of clinical trials of Rosinsulin M Mix 30/70, 2-phase genetically engineered human insulin, were presented in Rymar Oksana's report “Basic clinical and laboratory parameters in patients with type 2 diabetes mellitus amid the therapy of combined domestic insulins and metformins in the real-world clinical practice."
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130